Home › Funds › Advyzon Investment Management, LLC › GILD

Advyzon Investment Management, LLC position in GILD

GILEAD SCIENCES INC · Health Care

Advyzon Investment Management, LLC reported holding 8,887 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 0.44% of its reported portfolio and ranking #50 among its reported holdings. Advyzon Investment Management, LLC has disclosed GILD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)8.89K sh
Reported value held$4.17M
Portfolio Weight0.44%
First reportedQ4 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Advyzon Investment Management, LLC's GILD position evolved

Advyzon Investment Management, LLC first disclosed a stake in GILD in Q4 2024 at 4,523 shares (US$418K). The position peaked in Q3 2026 at 8,887 shares, worth US$4.2M. Across 8 filings, Advyzon Investment Management, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 8,887 shares valued at US$4.2M — an increase of 794 shares quarter over quarter.. Notable position changes include a 57% trim in Q1 2025 (shares were roughly flat over the following quarter), a 39% increase in Q3 2025 (shares rose 10% over the following quarter), a 169% increase in Q4 2025 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 4.52K $417.82K New
Q1 2025 1.95K $218.22K Reduce
Q2 2025 2.08K $230.92K Add
Q3 2025 2.89K $321.26K Add
Q4 2025 7.78K $955.31K Add
Q1 2026 7.53K $1.05M Reduce
Q2 2026 8.09K $1.02M Add
Q3 2026 8.89K $4.17M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Advyzon Investment Management, LLC held GILD?

Advyzon Investment Management, LLC has disclosed GILD holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Advyzon Investment Management, LLC's current position in GILD?

As of Q3 2026, Advyzon Investment Management, LLC holds 8.89K shares of GILD (GILEAD SCIENCES INC), valued at $4.17M, representing 0.44% of its reported portfolio and ranking #50.

Has Advyzon Investment Management, LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), Advyzon Investment Management, LLC increased its position in GILD. The position peaked in Q3 2026 at 8.89K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.